A Placebo-controlled, Single-blind, Randomised Study to Investigate the Safety, Tolerability, Pharmacokinetics and Drug Interaction of GSK1034702 After Repeat Doses in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 17 Jul 2017
At a glance
- Drugs GSK 1034702 (Primary) ; Dextromethorphan
- Indications Alzheimer's disease; Dementia; Schizophrenia
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- Sponsors GlaxoSmithKline
- 07 Apr 2011 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.
- 10 Aug 2009 New trial record